Document Detail


Use of nitric oxide synthase inhibitors as a novel treatment for septic shock.
MedLine Citation:
PMID:  7536056     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To review the current literature regarding the role of nitric oxide (NO) in the pathogenesis of septic shock and to describe the potential role of NO synthase (NOS) inhibitors in the treatment of septic shock. DATA SOURCES: A MEDLINE, Cancerlit, Biosis, Scisearch, CBAC, bibliography, and current journal search of applicable articles on the involvement of NO in mediating septic shock and the use of NOS inhibitors in septic shock was conducted. Articles that were searched included animal and human studies from January 1990 to August 1994. STUDY SELECTION: Because of the preliminary nature of the research involving NOS inhibitors in septic shock, all available studies were evaluated. DATA SYNTHESIS: NO appears to have a role in the mediation of the hemodynamic instability associated with septic shock. Cytokines and endotoxin stimulate synthesis of the inducible NOS, which produces large amounts of NO over an extended period of time. NO may be the key mediator in the pathogenesis of septic shock. Derivatives of the precursor to NO, L-arginine, have been used to investigate the role of NO in septic shock and as possible therapeutic agents. Comparison of study results among animal studies shows much variability. This variability may be attributable to differences in dosing regimens and models of septic shock. Data obtained from human studies are more consistent, but are limited to a few case series. Results indicate that NOS inhibitors increase blood pressure and systemic vascular resistance and decrease cardiac output. The effects of NOS inhibitors on morbidity and mortality have not been assessed because of the lack of an appropriate sample size. CONCLUSIONS: NO appears to play a role in septic shock; however, the use of NOS inhibitors to treat septic shock requires further studies to determine an appropriate dosing regimen and to determine the effects of these agents on morbidity and mortality.
Authors:
T A Wolfe; J F Dasta
Related Documents :
6831896 - Compared effects of selected colloids on extravascular lung water in dogs after oleic a...
8512886 - Brain injury causes loss of cardiovascular response to hemorrhagic shock.
1734856 - Hypertonic saline treatment of uncontrolled hemorrhagic shock at different periods from...
1394866 - In vivo assessment of regional microvascular albumin leakage during e. coli septic shoc...
2559236 - Effect of converting enzyme inhibition on the course of adriamycin-induced nephropathy.
17413566 - Anoxic ventilation improves systemic perfusion during extracorporeal circulation with u...
Publication Detail:
Type:  Comparative Study; Journal Article; Review    
Journal Detail:
Title:  The Annals of pharmacotherapy     Volume:  29     ISSN:  1060-0280     ISO Abbreviation:  Ann Pharmacother     Publication Date:  1995 Jan 
Date Detail:
Created Date:  1995-05-18     Completed Date:  1995-05-18     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9203131     Medline TA:  Ann Pharmacother     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  36-46     Citation Subset:  IM    
Affiliation:
College of Pharmacy, Ohio State University, Columbus 43210.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amino Acid Oxidoreductases / antagonists & inhibitors*,  therapeutic use
Animals
Arginine / analogs & derivatives,  pharmacology,  therapeutic use
Clinical Trials as Topic
Humans
NG-Nitroarginine Methyl Ester
Nitric Oxide / adverse effects*,  antagonists & inhibitors,  metabolism
Nitric Oxide Synthase
Shock, Septic / chemically induced,  drug therapy*,  physiopathology
omega-N-Methylarginine
Chemical
Reg. No./Substance:
10102-43-9/Nitric Oxide; 17035-90-4/omega-N-Methylarginine; 50903-99-6/NG-Nitroarginine Methyl Ester; 74-79-3/Arginine; EC 1.14.13.39/Nitric Oxide Synthase; EC 1.4.-/Amino Acid Oxidoreductases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cyclic GMP diffusion coefficient in rod photoreceptor outer segments.
Next Document:  Clinical and ethical perspectives on rationing of high-cost drugs.